Wells Fargo & Co. Vice President Kurt Lofrano played a “critical role” in helping the bank hide fraudulent home loans that cost the U.S. $189 million, the U.S. government claimed in a filing in Manhattan federal court.
AT&T Inc. agreed to pay $3.5 million in addition to $18.25 million it already paid to resolve allegations it overbilled the U.S. for a system for the deaf the company knew was used for fraudulent calls from other countries.
AstraZeneca Plc and Bristol-Myers Squibb Co. urged a Philadelphia federal appeals court not to revive a 10-year-old lawsuit alleging the drugmakers paid kickbacks to benefits manager Medco Health Solutions Inc.
Treasury Secretary Jacob J. Lew warned chief executive officers of top U.S. banks in a private meeting last month that the final Volcker rule ban on proprietary trading would be tougher than Wall Street expects, likely putting limits on portfolio hedging.
Johnson & Johnson agreed to resolve criminal and civil probes into the marketing of Risperdal, an antipsychotic drug, and other medicines by paying more than $2.2 billion, one of the largest U.S. health-fraud penalties.
The U.S. joined a whistle-blower lawsuit against the firm whose background checks helped National Security Agency leaker Edward Snowden and Washington Navy Yard shooter Aaron Alexis get security clearances.
Infosys Ltd., India’s second-largest software exporter, agreed to pay the U.S. a record $34 million in an immigration case to settle allegations the company abused a visa program intended for business travelers.